Breathing change into asthma care

References

  1. Australian Bureau of Statistics. Asthma. 2023;Dec. At: www.abs.gov.au/statistics/health/health-conditions-and-risks/asthma/latest-release
  2. Asthma Australia. Asthma burden in 2024. 2024;Dec. At: https://asthma.org.au/health-professionals/asthma-digest/asthma-burden-in-2024/
  3. Bateman ED, Reddel HK, O’Byrne PM, et al. As-needed budesonide-formoterol versus maintenance budesonide in mild asthma. N Eng J Med 2018;378:1877–87. At: www.nejm.org/doi/full/10.1056/NEJMoa1715275
  4. National Asthma Council Australia. Australian asthma handbook. Version 2.2. Melbourne: NACA; 2023. At: www.asthmahandbook.org.au
  5. Medicines and Healthcare products Regulation Agency. Short-acting beta 2 agonists (SABA) (salbutamol and terbutaline): reminder of the risks from overuse in asthma and to be aware of changes in the SABA prescribing guidelines. 2025;Apr. At: www.gov.uk/drug-safety-update/short-acting-beta-2-agonists-saba-salbutamol-and-terbutaline-reminder-of-the-risks-from-overuse-in-asthma-and-to-be-aware-of-changes-in-the-saba-prescribing-guidelines
  6. Bateman ED, O’Byrne PM, FitzGerald JM, et al. Positioning as-needed budesonide-formoterol for mild asthma: effect of prestudy treatment in pooled analysis of SYGMA 1 and 2. Ann Am Thorac Soc 2021;18(12):2007–17. At: https://pmc.ncbi.nlm.nih.gov/articles/PMC8750058/
  7. Asthma Australia. Medicines. MART: maintenance and reliever therapy. 2024;Nov. At: asthma.org.au/medicines/mart-maintenance-and-reliever-therapy/
  8. National Asthma Council Australia. Breathing life into asthma management. 2025;Mar. At: www.nationalasthma.org.au/news/2025/breathing-life-into-asthma-management-18-march-2025
  9. Queensland Health. Prescribing scope of practice management: prescribing in community pharmacy. 2025;Jul. At: www.health.qld.gov.au/__data/assets/pdf_file/0031/1450984/guidance-prescribing-scope-practice.pdf
  10. Chandrasekara S, Wark P. Biologic therapies for severe asthma with persistent type 2 inflammation. Aust Prescr 2024;47:36–42. At: https://australianprescriber.tg.org.au/articles/biologic-therapies-for-severe-asthma-with-persistent-type-2-inflammation.html
  11. Asthma Australia. Spirometry. 2025. At: https://asthma.org.au/health-professionals/asthma-digest/spirometry/  
  12. Asthma Australia. Medicines. Oral corticosteroids. 2025. At: https://asthma.org.au/medicines/oral-corticosteroids/   
  13. Cleveland Clinic. Monoclonal antibodies. 202. At: https://my.clevelandclinic.org/health/treatments/22246-monoclonal-antibodies